Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
NHS
Pharma
U.K. shuns immunocompromised, saying it won't buy AZ's Evusheld
The U.K. said it will not purchase AZ's Evusheld, citing “insufficient data” on the duration of protection it provides vs. omicron and its subvariants
Kevin Dunleavy
Aug 15, 2022 11:35am
NICE green lights PrEP treatment for prevention of HIV
Dec 15, 2021 10:45am
Costly decision: NICE rejects Pfizer heart disease drug Vyndaqel
May 12, 2021 10:01am
Amid Vertex-NHS deadlock, UK pharma lobby touts pricing teamwork
Jun 12, 2019 11:46am
NICE flip-flops to back Ionis rare disease treatment Tegsedi
Apr 16, 2019 11:15am
NICE issues preliminary ‘no’ on Alnylam’s and Ionis’ ATTR drugs
Dec 12, 2018 12:26pm